FTSE 100 movers: Miners slide as Astra gains on bid speculation
21st Aug 2014 18:01
Mining stocks led the downside after metals consumer China disappointed with its manufacturing data and metal prices fell. Fresnillo, Randgold Resources, Anglo American, Rio Tinto and BHP Billiton all fell into the red. BHP was still under pressure in the aftermath of Tuesday's underwhelming plans
Read moreSector movers: Astrazeneca boosts pharma stocks on Pfizer return hopes
21st Aug 2014 17:48
Astrazenca was leading the pharmaceuticals sector higher on Thursday on the back of speculation that US drug giant Pfizer could return with a fresh offer in the coming days. The reports lifted others in the sector higher in afternoon trading with peers such as Glaxosmithkline, Hikma and BTG making
Read moreLondon close: Astrazeneca leads FTSE higher on bid speculation
21st Aug 2014 17:42
- Healthcare stocks lift FTSE - German PMI data drives sentiment - Investors look ahead to Draghi speech - UK retail sales disappoint techMARK 2,819.77 +0.82% FTSE 100 6,777.66 +0.33% FTSE 250 15,838.57 +0.57% London's blue chips ended Thursday's session on a positive note, led by Astrazeneca. Inc
Read moreLondon midday: UK stocks advance as investors shrug off weak data
21st Aug 2014 12:01
- Mining stocks fall as Chinese data weakens - Eurozone PMIs and UK retail sales disappoint - US data, Jackson Hole ahead techMARK 2,810.76 +0.50% FTSE 100 6,772.04 +0.25% FTSE 250 15,797.15 +0.31% Falls in the heavyweight mining sector weren't enough to stop the FTSE 100 from advancing on Thursda
Read moreInvestigators linked with GSK will not appeal sentence
15th Aug 2014 12:37
A British corporate investigator and his wife, detained for the work they did for pharmaceuticals giant GSK, will not appeal a Chinese court's decision to sentence them to prison, Reuters reported on Friday. Peter Humphrey and his American wife Yu Yingzeng were sentenced to two and a half and two y
Read moreGSK faces bribery allegations in Syria
12th Aug 2014 11:53
GlaxoSmithKline (GSK) is facing claims it bribed Syrian distributors to increase its sales in the Arabic country, Reuters news agency said on Tuesday. The international pharmaceutical giant had previously come under scrutiny for corruption in its non-prescription business in Syria and bribery claim
Read moreSunday newspaper round-up: Barclays, Carillion-Balfour, Ofgem
10th Aug 2014 18:30
Rona Fairhead, the former boss of the Financial Times, and Howard Davies, the ex-chief City regulator, are the two leading candidates to chair Barclays, the Sunday Times reported. Fairhead ran the FT for seven years and is a non-executive director at HSBC. Davies is the Government's favourite troubl
Read moreChina charges couple linked to GSK bribery allegations
8th Aug 2014 10:30
A British investigator and his American wife were on Friday charged in China with illegally obtaining private information in a case that could provide details on the bribery probe against GlaxoSmithKline (GSK). Peter Humphrey and Yu Yingzeng, whose clients included GSK, were charged over a year aft
Read moreFriday newspaper round-up: Iraq, Tesco, RBS...
8th Aug 2014 06:45
Barack Obama has authorised targeted air strikes against Islamic militants in Iraq, as the US military began an airborne operation to bring relief to thousands of minority Iraqis driven to a grim, mountain-top refuge. Describing the threats against stranded Yezidi refugees as holding the potential f
Read moreFTSE 100 movers: Pharma stocks drop as regulation looks to derail M&A
6th Aug 2014 14:26
Shire, the pharmaceutical group which has agreed to a £32bn takeover by Abbvie, saw its shares decline sharply on Wednesday on concerns that stricter rules on so-called 'tax inversion' in the States could scupper the deal. Sector peer Astrazeneca, which had recently been the target of a failed £69b
Read moreSector movers: Shire and AZN lead pharma stocks lower on M&A risk
6th Aug 2014 14:13
The pharmaceutical sector dropped on Wednesday on the back of fears about risks to mergers and acquisitions (M&A) activity, with Shire sinking sharply. Concerns that stricter rules on so-called 'tax inversion' in the US could scupper Abbvie's £32bn takeover of London-listed Shire dented the latter'
Read moreLondon midday: FTSE 100 near 6,600 as Ukraine crisis sinks stocks
6th Aug 2014 12:09
- Russian troops amass along Ukraine border - UK, Italian and German data disappoints - Ex-dividend stocks fall - StanChart falls after results, Shire drops FTSE 100 6,604.48 -1.17% FTSE 250 15,162.03 -1.24% techMARK 2,708.06 -1.23% Fears about a possible Russian invasion of Ukraine sparked a sell
Read moreLondon open: UK stocks drop as Ukraine crisis intensifies
6th Aug 2014 09:10
- Russia builds up troop numbers along border - German factory orders slump 3.2% - Ex-div stocks fall, Sage rises after appointing new CEO techMARK 2,728.84 -0.47% FTSE 100 6,646.91 -0.53% FTSE 250 15,263.85 -0.57% UK stocks dropped on Wednesday morning as heightened geopolitical tensions hit risk
Read moreBroker tips: Barclays, Glaxosmithkline, Antofagasta...
30th Jul 2014 12:58
The stock market gave a warm reaction to Barclays' first-half results on Wednesday, with analysts upbeat about the bank's better-than-expected results. Numis Securities reiterated a 'buy' recommendation for the stock, saying that "Investment Bank revenues were better than feared, the balance sheet
Read moreLiberum downgrades Glaxo to 'sell' on uncertain outlook
30th Jul 2014 11:53
Liberum Capital has lowered its recommendation for pharmaceutical group Glaxosmithkline (GSK) from 'hold' to 'sell', saying it sees an uncertain outlook for the business. The broker has slashed its target price for the stock from 1,500p to 1,350p. "Our analysis shows the immense pressure the busin
Read more